參考文獻 |
1. Quan, T.E., S.E. Cowper, and R. Bucala, The role of circulating fibrocytes in fibrosis. Curr Rheumatol Rep, 2006. 8(2): p. 145-50.
2. Willis, B.C., R.M. duBois, and Z. Borok, Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc, 2006. 3(4): p. 377-82.
3. Kalluri, R. and E.G. Neilson, Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest, 2003. 112(12): p. 1776-84.
4. Wynn, T.A., Cellular and molecular mechanisms of fibrosis. J Pathol, 2008. 214(2): p. 199-210.
5. Henderson, N.C., F. Rieder, and T.A. Wynn, Fibrosis: from mechanisms to medicines. Nature, 2020. 587(7835): p. 555-566.
6. Salton, F., M.C. Volpe, and M. Confalonieri, Epithelial⁻Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis. Medicina (Kaunas), 2019. 55(4).
7. Lu, Q. and A.H.K. El-Hashash, Cell-based therapy for idiopathic pulmonary fibrosis. Stem Cell Investig, 2019. 6: p. 22.
8. Zoubek, M.E., C. Trautwein, and P. Strnad, Reversal of liver fibrosis: From fiction to reality. Best Pract Res Clin Gastroenterol, 2017. 31(2): p. 129-141.
9. Simon, T.G., et al., Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality. J Hepatol, 2021. 75(5): p. 1034-1041.
10. Abutaleb, A., et al., Higher Levels of Fibrosis in a Cohort of Veterans with Chronic Viral Hepatitis are Associated with Extrahepatic Cancers. J Clin Exp Hepatol, 2021. 11(2): p. 195-200.
11. Zhang, M., et al., Hepatic stellate cell senescence in liver fibrosis: Characteristics, mechanisms and perspectives. Mech Ageing Dev, 2021. 199: p. 111572.
12. Iredale, J.P., Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest, 2007. 117(3): p. 539-48.
13. Elpek, G., Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. World J Gastroenterol, 2014. 20(23): p. 7260-76.
14. Roehlen, N., E. Crouchet, and T.F. Baumert, Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells, 2020. 9(4).
15. Birgersdotter, A., R. Sandberg, and I. Ernberg, Gene expression perturbation in vitro--a growing case for three-dimensional (3D) culture systems. Semin Cancer Biol, 2005. 15(5): p. 405-12.
16. Edmondson, R., et al., Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol, 2014. 12(4): p. 207-18.
17. Baruffaldi, D., et al., 3D Cell Culture: Recent Development in Materials with Tunable Stiffness. ACS Appl Bio Mater, 2021. 4(3): p. 2233-2250.
18. Trédan, O., et al., Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst, 2007. 99(19): p. 1441-54.
19. Ho, W.J., et al., Incorporation of multicellular spheroids into 3-D polymeric scaffolds provides an improved tumor model for screening anticancer drugs. Cancer Sci, 2010. 101(12): p. 2637-43.
20. Langhans, S.A., Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning. Front Pharmacol, 2018. 9: p. 6.
21. Fang, Y. and R.M. Eglen, Three-Dimensional Cell Cultures in Drug Discovery and Development. SLAS Discov, 2017. 22(5): p. 456-472.
22. Groll, J., et al., Biofabrication: reappraising the definition of an evolving field. Biofabrication, 2016. 8(1): p. 013001.
23. Ozbolat, I.T. and M. Hospodiuk, Current advances and future perspectives in extrusion-based bioprinting. Biomaterials, 2016. 76: p. 321-43.
24. Gudapati, H., M. Dey, and I. Ozbolat, A comprehensive review on droplet-based bioprinting: Past, present and future. Biomaterials, 2016. 102: p. 20-42.
25. Klak, M., et al., Novel Strategies in Artificial Organ Development: What Is the Future of Medicine? Micromachines (Basel), 2020. 11(7).
26. Mandrycky, C., et al., 3D bioprinting for engineering complex tissues. Biotechnol Adv, 2016. 34(4): p. 422-434.
27. Kolesky, D.B., et al., 3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs. Adv Mater, 2014. 26(19): p. 3124-30.
28. Chattopadhyay, S. and R.T. Raines, Review collagen-based biomaterials for wound healing. Biopolymers, 2014. 101(8): p. 821-33.
29. Osidak, E.O., et al., Viscoll collagen solution as a novel bioink for direct 3D bioprinting. J Mater Sci Mater Med, 2019. 30(3): p. 31.
30. Rowley, J.A., G. Madlambayan, and D.J. Mooney, Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials, 1999. 20(1): p. 45-53.
31. Lee, K.Y. and D.J. Mooney, Alginate: properties and biomedical applications. Prog Polym Sci, 2012. 37(1): p. 106-126.
32. Gu, Z., et al., Development of 3D bioprinting: From printing methods to biomedical applications. Asian J Pharm Sci, 2020. 15(5): p. 529-557.
33. Jia, J., et al., Engineering alginate as bioink for bioprinting. Acta Biomater, 2014. 10(10): p. 4323-31.
34. Burdick, J.A., et al., Controlled degradation and mechanical behavior of photopolymerized hyaluronic acid networks. Biomacromolecules, 2005. 6(1): p. 386-91.
35. Sherman, L., et al., Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol, 1994. 6(5): p. 726-33.
36. Kobayashi, Y., A. Okamoto, and K. Nishinari, Viscoelasticity of hyaluronic acid with different molecular weights. Biorheology, 1994. 31(3): p. 235-44.
37. Yoon, H.J., et al., Cold Water Fish Gelatin Methacryloyl Hydrogel for Tissue Engineering Application. PLoS One, 2016. 11(10): p. e0163902.
38. Sun, M., et al., Synthesis and Properties of Gelatin Methacryloyl (GelMA) Hydrogels and Their Recent Applications in Load-Bearing Tissue. Polymers (Basel), 2018. 10(11).
39. Ma, C., et al., Mammalian and Fish Gelatin Methacryloyl-Alginate Interpenetrating Polymer Network Hydrogels for Tissue Engineering. ACS Omega, 2021. 6(27): p. 17433-17441.
40. Zhang, X., et al., Marine Biomaterial-Based Bioinks for Generating 3D Printed Tissue Constructs. Mar Drugs, 2018. 16(12).
41. Nichol, J.W., et al., Cell-laden microengineered gelatin methacrylate hydrogels. Biomaterials, 2010. 31(21): p. 5536-44.
42. Leu Alexa, R., et al., 3D-Printed Gelatin Methacryloyl-Based Scaffolds with Potential Application in Tissue Engineering. Polymers (Basel), 2021. 13(5).
43. Young, A.T., O.C. White, and M.A. Daniele, Rheological Properties of Coordinated Physical Gelation and Chemical Crosslinking in Gelatin Methacryloyl (GelMA) Hydrogels. Macromol Biosci, 2020. 20(12): p. e2000183.
44. Geiger, R.C., et al., Cyclic stretch-induced reorganization of the cytoskeleton and its role in enhanced gene transfer. Gene Ther, 2006. 13(8): p. 725-31.
45. Chhetri, A., J.V. Rispoli, and S.A. Lelièvre, 3D Cell Culture for the Study of Microenvironment-Mediated Mechanostimuli to the Cell Nucleus: An Important Step for Cancer Research. Front Mol Biosci, 2021. 8: p. 628386.
46. Balestrini, J.L. and K.L. Billiar, Equibiaxial cyclic stretch stimulates fibroblasts to rapidly remodel fibrin. J Biomech, 2006. 39(16): p. 2983-90.
47. Asmani, M., et al., Cyclic Stretching of Fibrotic Microtissue Array for Evaluation of Anti-Fibrosis Drugs. Cell Mol Bioeng, 2019. 12(5): p. 529-540.
48. Cui, Y., et al., Cyclic stretching of soft substrates induces spreading and growth. Nat Commun, 2015. 6: p. 6333.
49. Faust, U., et al., Cyclic stress at mHz frequencies aligns fibroblasts in direction of zero strain. PLoS One, 2011. 6(12): p. e28963.
50. Inoh, H., et al., Uni-axial cyclic stretch induces the activation of transcription factor nuclear factor kappaB in human fibroblast cells. Faseb j, 2002. 16(3): p. 405-7.
51. Sanger, F., S. Nicklen, and A.R. Coulson, DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A, 1977. 74(12): p. 5463-7.
52. Yohe, S. and B. Thyagarajan, Review of Clinical Next-Generation Sequencing. Arch Pathol Lab Med, 2017. 141(11): p. 1544-1557.
53. Mardis, E.R., Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet, 2008. 9: p. 387-402.
54. Nijman, I.J., et al., Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies. J Allergy Clin Immunol, 2014. 133(2): p. 529-34.
55. Meyerson, M., S. Gabriel, and G. Getz, Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet, 2010. 11(10): p. 685-96.
56. Warren, K.M., et al., 2D and 3D Mechanobiology in Human and Nonhuman Systems. ACS Appl Mater Interfaces, 2016. 8(34): p. 21869-82.
57. Tomasek, J.J., et al., Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol, 2002. 3(5): p. 349-63.
58. Kolahian, S., et al., Immune Mechanisms in Pulmonary Fibrosis. Am J Respir Cell Mol Biol, 2016. 55(3): p. 309-22.
59. Xu, R., Z. Zhang, and F.S. Wang, Liver fibrosis: mechanisms of immune-mediated liver injury. Cell Mol Immunol, 2012. 9(4): p. 296-301.
60. Wynn, T.A., Integrating mechanisms of pulmonary fibrosis. J Exp Med, 2011. 208(7): p. 1339-50.
61. Barron, L. and T.A. Wynn, Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages. Am J Physiol Gastrointest Liver Physiol, 2011. 300(5): p. G723-8.
62. Moore, B.B., et al., CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol, 2005. 166(3): p. 675-84.
63. Lin, C.H., et al., CXCL12 induces connective tissue growth factor expression in human lung fibroblasts through the Rac1/ERK, JNK, and AP-1 pathways. PLoS One, 2014. 9(8): p. e104746.
64. Wu, L., et al., Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways. Sci Rep, 2017. 7(1): p. 9289.
65. Wynn, T.A. and T.R. Ramalingam, Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med, 2012. 18(7): p. 1028-40.
66. Wynn, T.A., Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol, 2004. 4(8): p. 583-94.
67. Lamouille, S., J. Xu, and R. Derynck, Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol, 2014. 15(3): p. 178-96.
68. Gonzalez, D.M. and D. Medici, Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal, 2014. 7(344): p. re8.
69. Roeb, E., Matrix metalloproteinases and liver fibrosis (translational aspects). Matrix Biol, 2018. 68-69: p. 463-473. |